Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs Coivas
CoreAge Rx and Coivas both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxCoivas
Ranked #41 · Grade C
Best for: Anyone who needs one predictable monthly number to plan around and does not need brand-name Wegovy or an oral option.
Visit CoivasThe verdict
CoreAge Rx edges out Coivas on the Rx-Readiness Score, 95 to 69 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Coivas is still a genuine option — flat compounded pricing with the post-introductory number actually printed: $149 a month for semaglutide and $229 for tirzepatide, the same at every dose, after intro rates of $119 and $199. For planning purposes that flatness is the useful part — a titration step-up does not change the bill, so the number you budget in month one is the number in month six. All 50 states, and consultation, prescription, medication, shipping and support are inside the price. Watch the word "from" on every figure: the site says dosage and titration can move what you pay. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Coivas |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 69/100 · C |
| Overall rank | #1 | #41 |
| Semaglutide | $99/mo | $149/mo after the intro period |
| Tirzepatide | $149/mo | $229/mo after the intro period |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Coivas
Ranked #41 · Grade C
What we like
- Flat at every dose — the bill does not climb as you titrate
- Both the intro and the ongoing price are published on the same page
- All 50 states
The caveats
- $119 and $199 are introductory; the ongoing rates are $149 and $229
- Prices are prefixed "from" and the site says dosage and titration can change them
- Compounded only — no FDA-approved brand option
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Coivas against other providers on our shortlist.
Or browse the full comparison hub.